ProclaRx names Doug Martin COO
Biotechnology company ProclaRx named a new COO Aug. 17 as it continues to make changes to its executive team.
Doug Martin, who has assumed the position effective immediately, will be responsible for the strategic planning, compliance and coordination of R&D, the company said in a statement.
ProclaRx, based in Columbus, Ohio, works to eliminate the causes of chronic and recurrent human infections.
Before joining ProclaRx, Martin was the director of corporate strategy at Applied Bio Ventures. He was responsible for developing and implementing corporate structures that effectively funded the acquisition and development of biopharmaceutical intellectual property.
Prior to Applied Bio Ventures, Martin was the vice president and assistant general counsel of regulatory legal and government relations at the Fireman’s Fund Insurance Company, a subsidiary of Allianz Global Corporate & Specialty.
"I am honored to join the ProclaRx team of experienced scientists, researchers, and drug commercialization experts whose singular vision is to efficiently and effectively help children and adults with chronic and intractable infections," Martin said in a statement.
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.